Patients (N=40) Controls (N=30) P-Value
Age (years) 54.4 ± 16.3 49.8 ± 11.2 NS
Male/female(n/n) 15/25 12/18 NS
LA diameter(mm) 33.5 ± 3.4 34.2 ± 3.6 NS
LV EDD (mm) 43.1 ± 4.1 44.2 ± 4,9 NS
LV ESD (mm) 22.6 ± 2.7 24.4 ± 2.2 NS
RA diameter (mm) 33.5 ± 3.3 32.8 ± 3.1 NS
LVEF (%) 64.2 ± 5.2 64.8 ± 5.3 NS
BSA (m2) 1.9 ± 0.5 1.8 ± 0.3 NS
Heart rate (bpm) 75.9 ± 8.2 69.3 ± 5.3 NS
SPAP (mmHg) 28.5± 3.8 25.4 ± 3,4 NS
SBP (mmHg) 121 ± 23 122.5 ± 25 NS
DBP (mmHg) 74.2 ± 11 80.3 ± 12 NS
BMI (kg/m2) 25 ± 3.5 23 ± 3.1 NS
Smoking (n) 10 11 NS
LA: Left Atrium, LVEDD: Left Ventricular End-Diastolic Dimension, LVESD: Left Ventricular End-Systolic Dimension, RA: Right Atrium, LVEF: Left Ventricular Ejection Fraction, BSA: Body Surface Area, SPAP: Systolic Pulmoner Artery Pressure, SBP: Systolic Blood Pressure, DBP: Diastolic Blood Pressure, BMI: Body Mass Index
Table 1: Comparison of clinical and echocardiographic features of ASA patients and controls group.